Meeting of the Mine Safety and Health Research Advisory Committee, 15579-15580 [2024-04433]
Download as PDF
<![CDATA[
khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 89, No. 43 / Monday, March 4, 2024 / Notices
appropriate; (4) advise on grants,
cooperative agreements, contracts, or
other transactions, as applicable; (5)
provide other advice to the Director, as
requested, to fulfill duties under
sections 301 and 311; and (6) appoint
subcommittees. The ACD, CDC consists
of up to 15 non-federal members,
including the Chair, knowledgeable in
areas pertinent to the CDC mission, such
as health policy, public health, global
health, preparedness, preventive
medicine, the faith-based and
community-based sector, and allied
fields.
Purpose: The establishment and
formation of the ACD, Communications
and Public Engagement Workgroup
(CPEW) is to provide input to the
Committee on agency-wide activities
related to how CDC communicates
directly and more effectively with the
public, with a focus on reaching local
communities with messages. Effective
communication with the public
includes, but is not limited to: (1)
building relationships and mechanisms
to communicate via trusted messengers,
including but not limited to, clinicians,
faith and community leaders, and health
department officials at the national,
state and local levels; (2) improving risk
communication practices; (3) delivering
more action-oriented and focused
communications to help people protect
their health (e.g., effective messages and
storytelling); (4) tailoring our messages
and communications methods, as
appropriate, to audiences, particularly
for historically marginalized
communities; and (5) increasing
transparency by stepping up the pace,
content and reach of our
communications (e.g., considering
impact of different communications
channels, such as blogs, TV interviews,
emerging platforms).
The CPEW membership consists of
approximately 15 members. It is cochaired by two current ACD, CDC
Special Government Employees. The
CPEW co-chairs will present their
findings, observations, and work
products at one or more ACD, CDC
meetings for discussion, deliberation,
and decisions (final recommendations
to CDC).
Nomination Criteria: CPEW members
will serve terms ranging from six
months to one year and be required to
attend CPEW meetings approximately
once per month (virtually or in person),
and contribute time in between
meetings for research, consultation,
discussion, and writing assignments.
Nominations are being sought for
individuals who have the expertise and
qualifications necessary to contribute to
the accomplishments of the
VerDate Sep<11>2014
17:45 Mar 01, 2024
Jkt 262001
committee’s/workgroup’s objectives.
Nominees will be selected based on
expertise in the fields of
communications, including public
relations, health communication, risk
communication, communication
research, and marketing; community
and partner engagement; public health
science and practice, including
implementation; and behavioral
science/behavior change campaigns.
Federal employees will not be
considered for membership. Selection of
members is based on candidates’
qualifications to contribute to the
accomplishment of the CPEW’s
objectives.
HHS policy stipulates that
membership be balanced in terms of
points of view represented and the
workgroup’s function. Appointments
shall be made without discrimination
based on age, race, ethnicity, gender,
sexual orientation, gender identity, HIV
status, disability, and cultural, religious,
or socioeconomic status. Nominees
must be U.S. citizens and cannot be fulltime employees of the U.S. Government.
Current participation on federal
workgroups or prior experience serving
on a federal advisory committee does
not disqualify a candidate; however,
HHS policy is to avoid excessive
individual service on advisory
committees and multiple committee
memberships. Interested candidates
should submit the following items:
• A one-half to one-page cover letter
that includes your understanding of,
and commitment to, the time and work
necessary; one to two sentences on your
background and experience; and one to
two sentences on the skills/perspective
you would bring to the CPEW.
• At least one letter of
recommendation from person(s) not
employed by the U.S. Department of
Health and Human Services.
(Candidates may submit letter(s) from
current HHS employees if they wish,
but at least one letter must be submitted
by a person not employed by an HHS
agency (e.g., CDC, NIH, FDA, etc.).
• Current curriculum vitae which
highlights the experience and work
history being sought relevant to the
criteria set forth above, including
complete contact information
(telephone numbers, mailing address,
email address).
Nominations may be submitted by the
candidate him or herself, or by the
person/organization recommending the
candidate.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
15579
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–04430 Filed 3–1–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Meeting of the Mine Safety and Health
Research Advisory Committee
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC) announces the
following meeting of the Mine Safety
and Health Research Advisory
Committee (MSHRAC). This is a hybrid
meeting, accessible both in person and
virtually. It is open to the public and
limited only by the space available and
the number of web conference lines
available. Time will be available for
public comment.
DATES: The meeting will be held on
April 17, 2024, from 8:30 a.m. to 4:10
p.m., EDT.
ADDRESSES: Mine Safety and Heath
Administration’s Approval and
Certification Center, 765 Technology
Drive, Triadelphia, West Virginia 26059.
The conference room accommodates
approximately 49 people.
Please note that the meeting location
is a Federal facility and in-person access
is limited to U.S. citizens unless prior
authorizations, taking up to 30 to 60
days, have been made.
If you wish to attend the meeting
either in person or virtually, please
contact Ms. Berni Metzger by email at
Metzger@cdc.gov or by phone at (412)
386–4541 at least 5 business days in
advance of the meeting. If you are
attending virtually, she will provide you
with the Zoom web conference access
information (500 web conference lines
are available).
FOR FURTHER INFORMATION CONTACT:
Steven Mischler, Ph.D., Designated
Federal Officer, Mine Safety and Health
SUMMARY:
E:\FR\FM\04MRN1.SGM
04MRN1
15580
Federal Register / Vol. 89, No. 43 / Monday, March 4, 2024 / Notices
Research Advisory Committee, National
Institute for Occupational Safety and
Health, Centers for Disease Control and
Prevention, 626 Cochrans Mill Road,
Pittsburgh, Pennsylvania 15236.
Telephone: (412) 386–5688; Email:
SMischler@cdc.gov.
Purpose: The Mine Safety and Health
Research Advisory Committee is
charged with providing advice to the
Secretary, Department of Health and
Human Services; the Director, Centers
for Disease Control and Prevention; and
the Director, National Institute for
Occupational Safety and Health
(NIOSH), on priorities in mine safety
and health research, including grants
and contracts for such research, 30
U.S.C. 812(b)(2), Section 102(b)(2).
Matters To Be Considered: The agenda
will include discussions on NIOSH
mining safety and health research
organizational structure, capabilities,
projects, and outcomes, as well as a
verbal report from the Mace
Development Workgroup. The meeting
will also include an update from the
NIOSH Associate Deputy Director, Mine
Safety and Research. Agenda items are
subject to change as priorities dictate.
khammond on DSKJM1Z7X2PROD with NOTICES
Public Participation
Written Public Comment: The public
may submit written comments or
questions in advance of the meeting, to
the Designated Federal Officer (see FOR
FURTHER INFORMATION CONTACT above).
Written comments received in advance
of the meeting will be included in the
official record of the meeting, and
questions will be answered during the
oral comment period open to public
participation.
Oral Public Comment: The meeting
will include time for members of the
public to make an oral comment. The
public comment session will be held on
April 17, 2024, at 3:30 p.m., EDT, or the
conclusion of the planned
presentations, whichever comes first.
Members of the public will be allocated
5 to 10 minutes each for presentations
or comments, as a function of the
number of commenters.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
17:45 Mar 01, 2024
Jkt 262001
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–04433 Filed 3–1–24; 8:45 am]
SUPPLEMENTARY INFORMATION:
VerDate Sep<11>2014
Prevention and the Agency for Toxic
Substances and Disease Registry.
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Meeting of the Advisory Board on
Radiation and Worker Health, National
Institute for Occupational Safety and
Health
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control (CDC)
announces a meeting of the Advisory
Board on Radiation and Worker Health
(ABRWH or the Advisory Board). This
meeting is open to the public, with a
public comment period. The public is
welcome to submit written comments in
advance of the meeting, to the contact
person below. Written comments
received in advance of the meeting will
be included in the official record of the
meeting. The public is also welcomed to
listen to the meeting by joining the
teleconference (information below). The
audio conference line has 150 ports for
callers.
DATES: The meeting will be held on
April 17, 2024, from 9:15 a.m. to 6 p.m.,
EDT. A public comment session will be
held at 5 p.m. and will conclude at 6
p.m. or following the final call for
public comment, whichever comes first.
Written comments must be received
on or before April 10, 2024.
ADDRESSES: You may submit comments
by mail to: Rashaun Roberts, National
Institute for Occupational Safety and
Health, 1090 Tusculum Avenue, MS C–
24, Cincinnati, Ohio 45226.
Meeting Information: The USA tollfree dial-in numbers are: +1 669 254
5252 US (San Jose); +1 646 828 7666 US
(New York). The Meeting ID is: 160
6763 3819 and the Passcode is:
98685439; Web conference by Zoom
meeting connection: https://
cdc.zoomgov.com/j/16067633819?pwd=
RUdiYXlZZHFKanpJOHZrcG
JIbTlaZz09.
SUMMARY:
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
FOR FURTHER INFORMATION CONTACT:
Rashaun Roberts, Ph.D., Designated
Federal Officer, National Institute for
Occupational Safety and Health, Centers
for Disease Control and Prevention,
1090 Tusculum Avenue, Mailstop C–24,
Cincinnati, Ohio 45226, Telephone
(513) 533–6800, Toll Free 1(800) 232–
4636, Email: ocas@cdc.gov.
SUPPLEMENTARY INFORMATION:
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines
which have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule, advice on
methods of dose reconstruction which
have also been promulgated by HHS as
a final rule, advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program, and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC). In
December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS,
which subsequently delegated this
authority to the Centers for Disease
Control and Prevention (CDC). The
National Institute for Occupational
Safety and Health implements this
responsibility for CDC.
The charter was issued on August 3,
2001, renewed at appropriate intervals,
and rechartered under Executive Order
14109 on March 22, 2022, and will
terminate on March 22, 2024.
Purpose: This Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advising the Secretary
on whether there is a class of employees
at any Department of Energy (DOE)
facility who were exposed to radiation
but for whom it is not feasible to
estimate their radiation dose, and on
whether there is reasonable likelihood
that such radiation doses may have
endangered the health of members of
this class.
Matters to be Considered: The agenda
will include discussions on the
E:\FR\FM\04MRN1.SGM
04MRN1
]]>Agencies
[Federal Register Volume 89, Number 43 (Monday, March 4, 2024)]
[Notices]
[Pages 15579-15580]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-04433]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Meeting of the Mine Safety and Health Research Advisory Committee
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC) announces the
following meeting of the Mine Safety and Health Research Advisory
Committee (MSHRAC). This is a hybrid meeting, accessible both in person
and virtually. It is open to the public and limited only by the space
available and the number of web conference lines available. Time will
be available for public comment.
DATES: The meeting will be held on April 17, 2024, from 8:30 a.m. to
4:10 p.m., EDT.
ADDRESSES: Mine Safety and Heath Administration's Approval and
Certification Center, 765 Technology Drive, Triadelphia, West Virginia
26059. The conference room accommodates approximately 49 people.
Please note that the meeting location is a Federal facility and in-
person access is limited to U.S. citizens unless prior authorizations,
taking up to 30 to 60 days, have been made.
If you wish to attend the meeting either in person or virtually,
please contact Ms. Berni Metzger by email at [email protected] or by
phone at (412) 386-4541 at least 5 business days in advance of the
meeting. If you are attending virtually, she will provide you with the
Zoom web conference access information (500 web conference lines are
available).
FOR FURTHER INFORMATION CONTACT: Steven Mischler, Ph.D., Designated
Federal Officer, Mine Safety and Health
[[Page 15580]]
Research Advisory Committee, National Institute for Occupational Safety
and Health, Centers for Disease Control and Prevention, 626 Cochrans
Mill Road, Pittsburgh, Pennsylvania 15236. Telephone: (412) 386-5688;
Email: [email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The Mine Safety and Health Research Advisory Committee is
charged with providing advice to the Secretary, Department of Health
and Human Services; the Director, Centers for Disease Control and
Prevention; and the Director, National Institute for Occupational
Safety and Health (NIOSH), on priorities in mine safety and health
research, including grants and contracts for such research, 30 U.S.C.
812(b)(2), Section 102(b)(2).
Matters To Be Considered: The agenda will include discussions on
NIOSH mining safety and health research organizational structure,
capabilities, projects, and outcomes, as well as a verbal report from
the Mace Development Workgroup. The meeting will also include an update
from the NIOSH Associate Deputy Director, Mine Safety and Research.
Agenda items are subject to change as priorities dictate.
Public Participation
Written Public Comment: The public may submit written comments or
questions in advance of the meeting, to the Designated Federal Officer
(see FOR FURTHER INFORMATION CONTACT above). Written comments received
in advance of the meeting will be included in the official record of
the meeting, and questions will be answered during the oral comment
period open to public participation.
Oral Public Comment: The meeting will include time for members of
the public to make an oral comment. The public comment session will be
held on April 17, 2024, at 3:30 p.m., EDT, or the conclusion of the
planned presentations, whichever comes first. Members of the public
will be allocated 5 to 10 minutes each for presentations or comments,
as a function of the number of commenters.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-04433 Filed 3-1-24; 8:45 am]
BILLING CODE 4163-18-P
